Table 2 Immunohistochemical antibodies for differential diagnosis of GMNDI
From: Clinicopathological features and differential diagnosis of gastric metastases
Primary tumor | Antibodies |
|---|---|
Small cell lung cancer | CD56, CgA, Syn, CK, TTF-1 |
Non-small cell lung cancer | NapsinA, TTF-1, P40, CK5, P63 |
Breast cancer | ER, PR, Her-2, GATA-3, GCDFP-15 |
Hepatocellular carcinoma | GPC-3, Hepatocyte, Sall4 |
Malignant melanoma | HMB45, MelanA, S-100 |
Colorectal adenocarcinoma | CDX2, CK7, CK20, SATB2 |
Cholangiocarcinoma | CK19, S-100P, MUC-1, HNF-1β |
Renal cell carcinoma | CD10, PAX-8, CA9 |
Ovarian cancer | WT-1, P16 |
Prostate cancer | PSA, P504S, AR |
Germinoma | PLAP, CD30, HCG |